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To obtain light-controlled activation of myosin VI, we fused the portion of its cargo protein Dab2 (res. pep , which should amplify the switching capability of our design. 96 peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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Having established that Dab2 pep is sufficient for myosin VI recruitment, we next sought to re-117 engineer LOVDab +ctrl to have light-dependent binding. Our strategy focuses on caging the aromatic 118 residues F680, Y683, and F684 on the Dab2 pep 's N-terminal helix that are buried upon CBD binding 119 ( Figure 1A , right panel). These three residues must be close enough to the Jα helix that they are 120 sterically prevented from binding the CBD when the Jα helix is folded in the LOV2 dark state. This 121 peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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pep . An additional variable is 123 helical registry which controls the relative orientation of the Jα and the Dab2 pep helices, and therefore 124 the angle of the CBD-binding residues in Dab2 pep with respect to the LOV2 domain. Additionally, 125 disruption of the interaction between I539 on the Jα helix and the LOV2 core partially unfolds the Jα 126 helix (41). These constraints together limit the amount of Jα sequence we can modify. 127
We tested a small battery of constructs for light-dependent myosin VI binding using our 128 mitochondrial recruitment assay ( Figure 1B) . One construct, which we refer to as LOVDab ( Figure 1C) , 129 exhibits robust recruitment of myosin VI in response to light ( Figure 1D ). As intended, Tom70
helix -FP-130
LOVDab localizes to the surface of mitochondria, which are visible as puncta ( Figure 1D ). When the LOV2 131 is in the dark state, mCherry-myosin VI fluorescence shows a diffuse, cytosolic signature indicating that 132 it is unbound and diffuse throughout the cytosol. Upon LOV2 activation via whole cell illumination with a 133 blue, 488 nm laser, the myosin VI fluorescence is depleted from the cytosol and forms puncta 134 corresponding to the mitochondria where Tom70 helix -FP-LOVDab resides ( Figure 1D) peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/068965 doi: bioRxiv preprint first posted online Aug. We next targeted LOVDab to peroxisomes, and were able to achieve reversible, light-dependent 199 recruitment of myosin VI to this organelle (Figures 4A,B Myosin VI could halt peroxisome movements by binding to actin filaments either with or without motor 212 activity. In order to directly demonstrate activation of myosin VI motility by Dab2 pep , we designed a 213 modified gliding filament assay whereby we anchor an EGFP-LOV2-Dab2 pep fusion protein to the surface 214 of a glass coverslip through an anti-GFP antibody (3E6). We then perfused soluble mCherry-myosin VI 215 with actin together ( Figure 5A ). This design allows us to interrogate myosin VI activation without 216 altering its C-terminal cargo binding domain. 217
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When the coverslip is coated with LOVDab, myosin VI only recruits actin to the surface after the 225 LOV2 is excited with blue light (Figure 5B, Video 6) . After 400 seconds of excitation, the coverslip surface 226
is not yet saturated with actin, indicating that the actin deposits at a slower rate than with LOVDab +ctrl -227 coated coverslips. The velocity of the actin filaments recruited through LOVDab is similar to that of 228 filaments recruited through LOVDab +ctrl ( Figure 5C ). This latter finding suggests that both constructs fully 229 activate myosin VI. The slower deposition rate for LOVDab may be due to the lower availability of the 230
Dab2
pep in LOVDab over LOVDab +ctrl , leading to fewer recruited myosin VI motors. It could also reflect the 231 selective recruitment of microaggregates of myosin VI by LOVDab, which would diffuse to the surface 232 more slowly than monomeric myosin VI (see below). 233
For both constructs, myosin VI appears to be recruited to the surface irreversibly, as once the LOV2 234 was activated, actin did not release from the slide ( Figure 5B , lower panels). To determine whether this 235 irreversibility was due to the high affinity of Dab2 pep for the myosin VI CBD, we attempted to invert the 236 gliding filament assay to directly observe myosin VI walking on actin. However, we find that myosin VI 237 purified in low salt solutions forms soluble microaggregates which are visible as diffusing clusters in the 238 TIRF microscope. Testing a series of buffers, we find that myosin VI prepared in a high salt (KCl = 150 239 mM) Tris buffer does not form visible microaggregates. Myosin VI prepared in this second buffer is 240 active in the gliding filament assay when LOVDab +ctrl is on the surface. Consistent with a reduction in the 241 myosin:actin affinity in high salt, filaments recruited to the surface in this assay have a significantly 242 reduced velocity ( Figure 5C ). This myosin also did not perform in the TIRF assay, either because the 243 concentration needed to dimerize the myosin VI using cargo was prohibitively high for detection using 244
conditions (49, 50). 246
Unlike in low salt conditions, washing out free actin and myosin VI from the slide results in the slow 247 release of myosin VI from LOVDab +ctrl in high salt. (Figure 5D ) Together, the high off-rate of myosin VI 248 from the mitochondria and the reversibility in the high salt myosin VI preparation suggest that the 249 irreversibility seen in the gliding filament assays using myosin VI prepared in low salt was primarily due 250 to the presence of myosin VI microaggregates. However, without the high avidity of the myosin VI 251 microaggregates, we do not observe recruitment of actin to the surface via LOVDab under high salt 252 conditions. We postulate that the lack of myosin VI recruitment to LOVDab in vitro is due to the 253 engineered caging effect of the LOV2 domain on Dab2 pep in the LOVDab construct. This effect could 254 weaken the effective K D for binding of Dab2 pep to myosin VI to a point where even in the light, the 255 myosin VI cannot be recruited at concentrations where it is soluble in our high salt buffers. Alternatively, 256 the lifetime of the LOVDab:myosin VI:actin complex may be too short to propel the actin filaments. 257
Importantly, LOVDab containing an I539E point mutation that unfolds the Jα helix (41) constitutively 258 recruited actin in the presence of high salt myosin VI, proving that LOVDab is inherently capable of 259 activating myosin VI ( Figure 5D ). 260
We also tested whether a LOV2 domain fused to the myosin VI-binding residues (412-520) of 261 optineurin (OPTN) could activate myosin VI in our gliding filament assay. Though EGFP-LOV2-OPTN (412-520) 262 migrates as a dimer in size exclusion chromatography (Figure 5 -figure supplement 1) , it does not 263 activate myosin VI. Lack of activation is consistent with recent studies showing that the large insert in 264 the myosin VI tail domain, which is present in our construct, occludes the OPTN binding site (21) . 265
Furthermore, OPTN must be ubiquitinated prior to binding myosin VI (20) 2016; to the coverslip (Figure 6A ). This rescue requires the presence of Ca 2+ ions, suggesting that the three 271 signals, PI(4,5)P 2 , Ca 2+ and Dab2, are integrated to activate myosin VI in the proper time and place in the 272
cell. 273
This signal integration could explain recruitment of myosin VI to the Golgi via LOVDab with the KDEL 274 receptor (KDELR). Overexpression of KDELR seems to be cytotoxic. At low expression levels KDELR-FP-275
LOVDab recruits myosin VI to the Golgi apparatus in a light-dependent manner (Figure 6B,C; Video 7) . 276
However, the amount of myosin VI binding to each LOVDab-labeled membrane does not correlate with 277 the amount of LOVDab on that membrane (Figure 6B-D) . This lack of correlation cannot be explained by 278 limiting myosin VI since when light is applied to the cell, additional myosin VI binds to each membrane. 279
Thus, other factors on these membranes must alter the myosin VI affinity for its protein cargo Dab2 pep , 280 even between similar membranes. Together, these data support a new model of myosin VI activation 281 whereby myosin VI integrates multiple cargo signals to deploy in a site-specific manner in the cell 282 ( Figure 6E , see discussion below). The presence of these signals in vivo also may explain why myosin VI is 283 activated by LOVDab in vivo but not in our in vitro gliding filament assay. 284
Discussion
285
Myosin VI is the only myosin that walks toward the pointed end of actin filaments (5, 6). This property 286
gives it many unique roles throughout the cell including endocytosis, cell migration, and autophagy (51). 287 Furthermore, the mechanism for myosin VI activation is still highly debated (13). To create a tool that 288 could help address these questions, we engineered an optogenetic activator of myosin VI, LOVDab. 289 peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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and Ca 2+ signals to perform its function in a site-specific manner. 339
Our findings therefore support a new model of myosin VI activation where, rather than having a 340 given cargo for a given function, myosin VI integrates multiple signals on a given membrane to modulate 341 binding and motor activation (Figure 6E) . Regulation through splicing biases myosin VI to certain protein 342 cargo adaptors (21) . The protein cargos regulate the localization of myosin VI in the cell, and may also be 343 the primary determinant of myosin VI's oligomeric state (4). Once on-site, secondary cargo signals such 344 as lipids or Ca 2+ may fine-tune myosin VI's activity at that location by increasing myosin VI's effective 345 affinity for its substrate, driving local activation (24). 346
LOVDab is a unique optogenetic tool in that it activates full-length myosin VI without altering the 347 myosin itself, allowing for direct inferences on myosin VI activity and regulation in vitro and in vivo. Our 348 approach here could guide similar optogenetic efforts to control native systems with minimal 349 perturbation. LOVDab exhibits robust, light-dependent myosin VI recruitment to many different 350 organelles, and myosin binding to LOVDab propels actin filaments in vitro. Using LOVDab, we discovered 351 evidence for a new activation model for human myosin VI, whereby myosin VI integrates its activation 352 signals to obtain a site-specific mode of activation. How each of these cargos are integrated, and how 353 this integration is reflected structurally in myosin VI, are outstanding questions. In particular, the 354 relation between the oligomeric state of myosin VI and its site-specific roles in the cell, and how this is 355 impacted by different cargos, is not entirely known. We believe that LOVDab will be an extremely useful 356 tool for answering these and additional questions about how this important motor protein functions in 357 the cell. 358
For protein purification, plasmids encoding LOV2-Dab2 pep fusion proteins were engineered within a 361 pHISparallel1 vector encoding a modular -/NdeI/-His6-Protein G-/AgeI/-EGFP-/EcoRI/-LOV2-Dab2 pep -362 /XhoI/-that allowed for facile swapping of domains via ligation. Full-length myosin VI was incorporated 363 into baculovirus for expression in SF9 cells using the BestBac system by Expression Systems (Nevada, 364 USA) according to the manufacturer's guidelines. An mCherry2B (58) with an N-terminal FLAG tag was 365 first incorporated at the myosin VI N-terminus within the pET vector (see below) prior to insertion into a 366 modified pBlueBac plasmid via SLiCE cloning due to the large sizes of the fragments (59). We fused 367 mCherry2B to its to improve solubility, reduce dimerization, and increase fluorescence of the protein 368 over mCherry (58) . was spun at 14,000 rpm in a Legend X1R centrifuge (F15S-8x50c rotor, Thermo Scientific) and a variable 396 amount of anti-FLAG resin (M2, Sigma) added to the supernatant. After incubation, the resin was spun 397 out of suspension at 900xg in a 5810R centrifuge (A-4-81 rotor, Eppendorf) and washed with wash 398 buffer (see below) containing 3 mM ATP, a variable amount of Calmodulin, and protease inhibitors. 399
Resin was repelleted using the same procedure and re-suspended in wash buffer before transferred to a 400 drip column where the resin was further washed. Resin was then incubated with elution buffer (wash 401 buffer + 0.2 mg/mL FLAG peptide) for 1 hour. Protein was eluted and dialyzed against wash buffer 402 containing no ATP or protease inhibitors. In the low salt preps (see text) the lysis buffer was 50 mM 403
Tris·HCl, 150 mM KCl, 0.5 mM DTT, and 0.1% Triton X-100, pH = 7.7. The wash buffer was 20 mM 404 imidazole, 150 mM KCl, 5 mM MgCl 2 , 1 mM EDTA, and 1 mM EGTA, and 0.5 mM DTT, pH = 7.5. The 405 peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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For the high salt prep, the lysis buffer was 50 mM Tris·HCl, 150 mM KCl, 0.5 mM EDTA, 1 mM EGTA, 4 408 mM MgCl 2 , 0.5 mM DTT, and 0.1% Triton X-100, pH = 7.3, and the final dialysis/assay buffer was 50mM 409
Tris·HCl, 150 mM KCl, 1 mM EDTA, 1mM EGTA, 5 mM MgCl2, and 0.5 mM DTT (1 mM DTT for final 410 dialysis), pH = 7.3. For both preps, buffers were chilled to 0-4ᵒC before use. pH values were set at room 411 temperature. 412
Protein purity was assessed using SDS-PAGE. In the case of LOV2-containing constructs, protein 413 quality was further assessed using UV-Vis spectroscopy to measure the FMN photorecovery rate and 414 circular dichroism (CD) (see below) to measure the fractional change in helicity of the protein, as done 415 previously in our lab (36). The UV-Vis spectroscopy was carried out on an Olis HP 8452 Diode Array 416
Spectrophotometer (Bogart, GA). The recovery of FMN absorbance at 448 nm was fit to a single 417 exponential using MATLAB to obtain the FMN dark state recovery time constant, τ FMN . Circular dichroism 418 (CD) was performed on a Jasco 715 spectrophotometer and a 40W white LED lamp (BT DWNLT A, 419
TheLEDLight.com) was used to excite the LOV2 domain in the cuvette for ≥ 12 seconds for photo 420 excitation. The refolding traces at 222 nm were fit to a single exponential using MATLAB and the 421 fractional change in helicity in the protein as δ 222 = (CD 222,dark -CD 222,light )/CD 222,dark . 422
Gliding filament assay 423
Nitrocellulose-coated coverslips were first coated in anti-GFP antibody (clone 3E6 MP Biomedicals, 424 California, USA) at 0.25 µg/mL in PBS. Following this, coverslips were blocked using 1 mg/mL BSA (ELISA 425 grade, EMD Millipore) and the antibody saturated using EGFP-LOV2-Dab2 pep at 1 µM. After this, the slide 426 was washed using KMg25 and a solution containing myosin VI, F-actin, and an oxygen scavenging system 427 (0.45% glucose (w/v) 0.5% (v/v) BME, 432 µg/mL glucose oxidase, and 72 µg/mL catalase) (63) was 428 perfused. Slides were then imaged using an x100, 1.65 NA objective (Olympus) on a custom-built total 429 peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission. of the signaling lipid PI(4,5)P 2 were added to the assay buffer. The liposomes had no effect on myosin VI 433 activity if Ca 2+ was not present at a total concentration of at least 1.5 mM (corresponding to a free Ca Gliding filament velocities were calculated from at least 3 videos from at least 2 independent 438 preparations of myosin VI, using at least 10 filaments/video and at least 10 frames/filament. MTrackJ 439 was used to generate the actin tracks (64). Filaments showing smooth and continuous movement were 440 tracked. To quantify the length of actin on the coverslip, images were background subtracted and 441 thresholded to create binary images of the actin that were then skeletonized using the ImageJ function. 442
The sum of pixels in the images were converted to length using the pixel calibration and used as the 443 estimate for the length of actin on the coverslip. peer-reviewed) is the author/funder. All rights reserved. No reuse allowed without permission.
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Figure 5-figure supplement 1. EGFP-LOV2 fused to the myosin VI-binding portion of Optineurin migrates as a dimer by size exclusion chromatography. Optineurin (OPTN) has previously been shown to activate full-length porcine myosin VI at much lower concentrations than a truncated portion of Dab2 containing Dab2 pep (4). We therefore wanted to test whether the putative myosin VI binding site on OPTN (res. 412-520) could activate full-length human myosin VI in our gliding filament assay. Comparison to the elution trace of EGFP-LOVDab +ctrl dimerized via a GCN4 leucine zipper, OPTN fused to the C-terminus of EGFP-LOV2 migrates as a dimer in our size exclusion column. This is consistent with previous reports showing OPTN is a dimer (4) and the prediction that these residues in OPTN form a coiled-coil (14, 15). However, EGFP-LOV2-OPTN (412-520) did not recruit actin to the surface of our gliding filament assay, seemingly inconsistent with the study showing activation of porcine myosin VI via optineurin. (4). Though OPTN binding to the myosin VI tail was shown to be large insert independent (19), one difference between porcine myosin VI and our human full length construct is that our construct contains the large insert of isoform 1. Since doing this experiment, a group of researchers have shown that myosin VI binds OPTN only after it has been ubiquitinated (20), and have solved the structure of a molecular "switch" region in the tail domain involving the long insert that occludes the OPTN binding site (21) . Our results therefor support their findings.
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